Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream")

Newnham, D M; Lipworth, B J
August 1994
Thorax;Aug1994, Vol. 49 Issue 8, p762
Academic Journal
No abstract available.


Related Articles

  • The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro. Stern, M; Sorgi, F; Hughes, C; Caplen, N J; Browning, J E; Middleton, P G; Gruenert, D C; Farr, S J; Huang, L; Geddes, D M; Alton, E W F W // Gene Therapy;May98, Vol. 5 Issue 5, p583 

    Nebulisation is currently the most acceptable and practical delivery system for repeated applications of gene therapy to the lower airways of cystic fibrosis (CF) patients. We have assessed whether this route of administration offers other benefits with regard to respiratory gene transfer. A...

  • Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser. Silkstone, V. L.; Corlett, S. A.; Chrystyn, H. // European Journal of Clinical Pharmacology;Jan2002, Vol. 57 Issue 11, p781 

    Objective: To compare the lung and systemic delivery of salbutamol following inhalation from a metered dose inhaler (MDI), a MDI attached to a spacer (MDI+SP) and a nebuliser (NEB) using a urinary pharmacokinetic method. Method: Twelve healthy subjects each provided urine samples at 0, 30 min...

  • Randomised controlled crossover trial of the effect on PtCO2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease. Edwards, Llifon; Perrin, Kyle; Williams, Mathew; Weatherall, Mark; Beasley, Richard // Emergency Medicine Journal;Nov2012, Vol. 29 Issue 11, p894 

    Background The comparative safety of oxygen versus air-driven nebulised bronchodilators in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) is uncertain. A randomised controlled trial was performed to assess the effect on the arterial partial pressure of carbon...

  • Potential hazard of nebulised salbutamol in patients with haemoptysis.  // British Medical Journal (Clinical Research Edition);3/12/1983, Vol. 286 Issue 6368, p844 

    Investigates the potential hazard of nebulised salbutamol in patients with haemoptysis. Physiologic effects of salbutamol; Citation of a case report on a patient with bronchiectasis; Effects of intercurrent infection on intermittent haemoptysis and bronchiectasis.

  • Pharmacological Factors that Influence the Choice of Inhaled Corticosteroids. Edsbacker, S. // Drugs;Dec1999 Supplement 4, Vol. 58 Issue 6, p7 

    Local therapeutic effect relative to the risk of adverse effects of inhaled drugs, i.e. airway selectivity, is determined by the efficiency of the delivery system and the physicochemical and pharmacokinetic properties of the drug molecule. For the inhaled corticosteroid formulations, many of the...

  • Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Lawford, P.; Jones, B.J.M.; Milledge, J.S. // British Medical Journal;1/14/1978, Vol. 1 Issue 6105, p84 

    Salbutamol has been assessed in the initial treatment of acute severe, asthma[1, 2] but the optimum route and duration of administration have not been established. We have compared the effects of salbutamol given by intravenous infusion with those of wet, nebulised salbutamol in a randomised,...

  • Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers. Dempsey, Owen J.; Humphreys, Mark; Coutie, Wendy J.; Lipworth, Brian J. // European Journal of Clinical Pharmacology;Nov2001, Vol. 57 Issue 9, p637 

    Objectives: High-dose nebulised fluticasone propionate (FP) has been advocated for use in patients with severe persistent asthma. As there is complete first-pass inactivation of FP for the swallowed fraction, systemic absorption is due solely to its lung bioavailability. We wished to compare the...

  • Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium. Manunta, Maria D. I.; McAnulty, Robin J.; Tagalakis, Aristides D.; Bottoms, Stephen E.; Campbell, Frederick; Hailes, Helen C.; Tabor, Alethea B.; Laurent, Geoffrey J.; O'Callaghan, Christopher; Hart, Stephen L. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Background: Gene therapy mediated by synthetic vectors may provide opportunities for new treatments for cystic fibrosis (CF) via aerosolisation. Vectors for CF must transfect the airway epithelium efficiently and not cause inflammation so they are suitable for repeated dosing. The inhaled...

  • Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments. Jones, L A; Goodacre, S // Emergency Medicine Journal;Nov2009, Vol. 26 Issue 11, p783 

    Background: A recent meta-analysis showed that intravenous and nebulised magnesium sulphate have similar levels of evidence to support their use in the treatment of acute asthma in adults. This consisted of weak evidence of effect on respiratory function and hospital admissions, with wide...

  • Nebulisers -- a timely warning. Taylor, Robin // New Zealand Doctor;7/30/2008, p14 

    The author encourages general practitioners (GPs) to examine the use of nebulisers by their patients. He mentions a study which found that the effectiveness of the use of a metered dose inhaler with a spacer is similar to a nebuliser. He cites evidence of the side effects of regular nebulised...


Read the Article


Sign out of this library

Other Topics